Furthermore, the exogenous administration of siRNA targeting VASH2 with atelocollagen biomaterial to a murine xenograft model of ovarian cancer retarded tumor growth by suppressing angiogenesis.13 Here, VASH2 is linked to ovarian carcinoma.